image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Scapa

July 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SCPA
  • Price:
  • 120p
Scapa has raised £30m from a 19.9% placing of new shares, with senior management subscribing for £335,000. The proceeds are being used to strengthen its balance sheet. With the placing, the company expects net debt of £34m at the end of FY’21, or net debt / ebitda of c.1.4x (versus 2.6x without the placing). Scapa has received credit committee approval for a new £15m short-term banking facility to sit alongside its existing £80m facility, so there is now ample headroom. It’s also started applications to Government schemes in France, Italy and the UK. In the US, it’s been approved for a US$5m grant (a loan that will be forgiven if Scapa’s headcount isn’t reduced for a period of 8 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X